journal article·2019-12

Crystal structure of ( Z )-cefprozil monohydrate, C 18 H 19 N 3 O 5 S(H 2 O)

Zachary R. Butler, James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 34· Issue 4
Publisher page

Abstract

The crystal structure of cefprozil monohydrate has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Cefprozil monohydrate crystallizes in space group P 2 1 (#4) with a = 11.26513(6), b = 11.34004(5), c = 14.72649(11) Å, β = 90.1250(4)°, V = 1881.262(15) Å 3 , and Z = 4. Although a reasonable fit was obtained using an orthorhombic model, closer examination showed that many peaks were split and/or had shoulders, and thus the true symmetry was monoclinic. DFT calculations revealed that one carboxylic acid proton moved to an amino group. The structure thus contains one ion pair and one pair of neutral molecules. This protonation was confirmed by infrared spectroscopy. There is an extensive array of hydrogen bonds resulting in a three-dimensional network. The powder pattern has been submitted to ICDD ® for inclusion in the Powder Diffraction File™.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Thermal and Kinetic Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Hoshi H. , Okumura J. , Naito T. , Abe Y. , and Aburaki S. (1985). “Substituted vinyl cephalosporins,” US Patent 4,520,022.
2. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
3. Turner · 2017
4. Strickland · 2006 · 561
5. 2018
6. 10.1107/S090744490804362X10.1107/S090744490804362X ↗
7. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
8. 2018
9. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
10. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
11. Open Babel: an open chemical toolbox
12. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
13. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
14. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
15. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
16. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
17. Bravais · 1866
18. 10.1017/S088571561700028810.1017/S0885715617000288 ↗
19. 10.1021/ci049780b10.1021/ci049780b ↗
20. Crast L. B. Jr. (1987). “3-propenyl cephalosporin solvates,” US Patent 4,694,079.
21. 10.1107/S002188980604211710.1107/S0021889806042117 ↗
22. A new law of crystal morphology extending the law of Bravais
23. 10.1002/qua.2465810.1002/qua.24658 ↗
24. Etudes sur la loi de Bravais
25. Liu C. , Song L. , Zheng X. , Fu D. , and Kang Y. (2015). “Preparation method of cefprozil monohydrate,” Chinese Patent CN102408438B.
26. 10.1063/1.46788210.1063/1.467882 ↗
27. 10.1007/BF0054909610.1007/BF00549096 ↗
28. 10.1007/BF0119005210.1007/BF01190052 ↗
29. Kumar Y. , Tewari N. , Singh S. K. , and Rai B. P. (2004). “Solvates of cefprozil,” International Patent Application WO 2004/110399 A2.
30. 2016
31. 10.1103/PhysRevLett.78.406310.1103/PhysRevLett.78.4063 ↗
32. 10.1002/jcc.2315310.1002/jcc.23153 ↗
33. Qing S. (2014). “Cefprozil compound, and dispersible tablets, dry suspension and preparation method thereof,” Chinese Patent CN103524533A.
34. 10.1107/S010827019200049010.1107/S0108270192000490 ↗
35. 2013
36. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
37. 10.1063/1.296926010.1063/1.2969260 ↗
38. 10.1017/S088571561800082910.1017/S0885715618000829 ↗
39. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
40. 2018
41. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗